Henry Schein (HSIC) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of Henry Schein (NASDAQ:HSIC) from a buy rating to a strong-buy rating in a report published on Thursday morning.

Several other equities research analysts have also issued reports on HSIC. Zacks Investment Research upgraded shares of Henry Schein from a hold rating to a buy rating and set a $86.00 price target on the stock in a research note on Wednesday, July 25th. Stifel Nicolaus lifted their price target on shares of Henry Schein from $76.00 to $81.00 and gave the company a hold rating in a research note on Tuesday, August 7th. Barrington Research reiterated a buy rating and issued a $92.00 price target on shares of Henry Schein in a research note on Tuesday, August 7th. Craig Hallum lifted their price target on shares of Henry Schein from $83.00 to $96.00 and gave the company a buy rating in a research note on Tuesday, August 7th. Finally, Robert W. Baird lifted their price target on shares of Henry Schein from $90.00 to $95.00 and gave the company an outperform rating in a research note on Thursday, October 4th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $83.53.

Shares of HSIC stock opened at $83.51 on Thursday. The company has a current ratio of 1.29, a quick ratio of 0.68 and a debt-to-equity ratio of 0.34. Henry Schein has a 1 year low of $62.56 and a 1 year high of $90.52. The firm has a market capitalization of $12.79 billion, a price-to-earnings ratio of 23.20, a price-to-earnings-growth ratio of 2.55 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.03. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.31 billion. During the same period in the previous year, the business earned $0.88 EPS. The company’s revenue was up 8.7% compared to the same quarter last year. Research analysts expect that Henry Schein will post 4.12 EPS for the current year.

Several institutional investors have recently added to or reduced their stakes in the company. FMR LLC grew its stake in Henry Schein by 167.3% in the 2nd quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after buying an additional 4,151,179 shares during the last quarter. Point72 Asset Management L.P. grew its stake in Henry Schein by 2,573.5% in the 2nd quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock valued at $58,261,000 after buying an additional 772,047 shares during the last quarter. American Century Companies Inc. grew its stake in Henry Schein by 21.2% in the 2nd quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock valued at $159,202,000 after buying an additional 383,479 shares during the last quarter. Glenmede Trust Co. NA grew its stake in Henry Schein by 11,084.6% in the 2nd quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock valued at $25,787,000 after buying an additional 351,826 shares during the last quarter. Finally, Janus Henderson Group PLC grew its stake in Henry Schein by 7.1% in the 2nd quarter. Janus Henderson Group PLC now owns 3,180,363 shares of the company’s stock valued at $231,022,000 after buying an additional 209,562 shares during the last quarter.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Return on Equity (ROE)

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply